Biomedicines (Oct 2023)

The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models

  • Laura Palumbo,
  • Marianna Carinci,
  • Annunziata Guarino,
  • Laila Asth,
  • Silvia Zucchini,
  • Sonia Missiroli,
  • Alessandro Rimessi,
  • Paolo Pinton,
  • Carlotta Giorgi

DOI
https://doi.org/10.3390/biomedicines11102825
Journal volume & issue
Vol. 11, no. 10
p. 2825

Abstract

Read online

Neuroinflammation represents a dynamic process of defense and protection against the harmful action of infectious agents or other detrimental stimuli in the central nervous system (CNS). However, the uncontrolled regulation of this physiological process is strongly associated with serious dysfunctional neuronal issues linked to the progression of CNS disorders. Moreover, it has been widely demonstrated that neuroinflammation is linked to epilepsy, one of the most prevalent and serious brain disorders worldwide. Indeed, NLRP3, one of the most well-studied inflammasomes, is involved in the generation of epileptic seizures, events that characterize this pathological condition. In this context, several pieces of evidence have shown that the NLRP3 inflammasome plays a central role in the pathophysiology of mesial temporal lobe epilepsy (mTLE). Based on an extensive review of the literature on the role of NLRP3-dependent inflammation in epilepsy, in this review we discuss our current understanding of the connection between NLRP3 inflammasome activation and progressive neurodegeneration in epilepsy. The goal of the review is to cover as many of the various known epilepsy models as possible, providing a broad overview of the current literature. Lastly, we also propose some of the present therapeutic strategies targeting NLRP3, aiming to provide potential insights for future studies.

Keywords